중재적 종양학 기기 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 시술별, 암 종류별, 지역별, 경쟁별(2020-2030년)

Interventional Oncology Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Procedure, By Cancer Type, By Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,681,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 8,165,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,877,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 중재적 종양학 기기 시장은 2024년에 27억 4,000만 달러로 평가되었으며, 2030년까지 CAGR 7.90%로 성장하여 43억 2,000만 달러에 달할 것으로 예측됩니다.

인중재적 종양학 기기는 영상 유도하에 시행되는 최소침습적 시술에서 다양한 암의 진단, 치료, 완화에 사용되는 전문 의료기기를 말합니다. 시장 확대의 주요 요인은 전 세계적으로 암 발병률이 증가하고 있으며, 회복 기간 단축 및 합병증 감소와 같은 이점을 제공하는 최소침습적 치료 중재에 대한 수요가 증가하고 있기 때문입니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	27억 4,000만 달러
시장 규모 : 2030년	43억 2,000만 달러
CAGR : 2025-2030년	7.9%
가장 빠르게 성장하는 부문	절제 기기
최대 시장	북미

주요 시장 촉진요인

주요 시장 과제

이러한 부족은 환자들이 고도의 치료적 개입을 받을 수 있는 기회를 제한하고, 시장의 성장 잠재력을 제한하고 있습니다.

주요 시장 동향

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 중재적 종양학 기기 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 제품별(색전 기기, 절제 기기, 서포트 기기)
  • 치료법별(열 종양 절제, 비열 종양 절제, 경카테터 동맥 화학 색전요법(TACE), 경카테터 동맥 방사선 색전요법(TARE), 경카테터 동맥 색전요법(TAE))
  • 암 종류별(간, 신장, 폐, 골, 기타)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 중재적 종양학 기기 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 중재적 종양학 기기 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 중재적 종양학 기기 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 중재적 종양학 기기 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 중재적 종양학 기기 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 중재적 종양학 기기 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• Medtronic PLC
• Terumo Corporation
• Boston Scientific Corporation
• Merit Medical Systems, Inc.
• HealthTronics, Inc.
• Johnson & Johnson
• Teleflex Inc.
• Angiodynamics Inc.
• MedWaves, Inc.
• Becton, Dickinson, and Company

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

KSM

영문 목차

영문목차

The Global Interventional Oncology Devices Market, valued at USD 2.74 Billion in 2024, is projected to experience a CAGR of 7.90% to reach USD 4.32 Billion by 2030. Interventional oncology devices represent specialized medical instrumentation employed in image-guided, minimally invasive procedures for the diagnosis, treatment, and palliation of various cancers. The market's expansion is fundamentally driven by the increasing global prevalence of cancer and a growing preference for less invasive therapeutic interventions, which offer advantages such as reduced recovery times and fewer complications.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.74 Billion
Market Size 2030	USD 4.32 Billion
CAGR 2025-2030	7.9%
Fastest Growing Segment	Ablation Devices
Largest Market	North America

Key Market Drivers

The increasing global cancer incidence is a significant catalyst for the interventional oncology devices market, generating an expanding patient demographic in need of advanced diagnostic and treatment modalities. The rising number of new cancer diagnoses globally creates a fundamental demand for minimally invasive, image-guided interventions that offer targeted therapy with reduced systemic impact. For example, according to the "Global Cancer Statistics, 2024" report published by the American Cancer Society and the International Agency for Research on Cancer on April 4, 2024, lung cancer was the most frequently diagnosed cancer in 2022, accounting for 2.5 million new cases worldwide, underscoring the substantial and ongoing demand for specialized oncology solutions. This growing burden necessitates a wider array of effective and less invasive tools, directly stimulating the development and adoption of interventional oncology devices.

Key Market Challenges

A notable challenge impeding market expansion is the limited availability of adequately trained interventional oncologists. These specialized medical procedures necessitate a high degree of expertise in image-guided, minimally invasive techniques, making the presence of skilled professionals critical for the adoption and utilization of associated devices. A deficiency in this expert workforce directly restricts the number of procedures that can be performed, thereby hampering the overall demand for interventional oncology instruments.

This scarcity limits patient access to advanced therapeutic interventions and constrains the market's growth potential.

Key Market Trends

Artificial Intelligence and Machine Learning Integration for Precision marks a significant trend in the Global Interventional Oncology Devices Market by refining diagnostic accuracy and therapeutic targeting. The application of sophisticated algorithms allows for the analysis of complex patient data, including genomics and imaging, to guide more precise interventions. According to a EuroAIM/EuSoMII 2024 survey, nearly 48% of European Society of Radiology members are currently using AI systems in their clinical practice, indicating a notable adoption rate within a directly relevant medical specialty. This integration facilitates optimized treatment pathways and improved patient stratification.

Key Market Players

• Medtronic PLC
• Terumo Corporation
• Boston Scientific Corporation
• Merit Medical Systems, Inc.
• HealthTronics, Inc.
• Johnson & Johnson
• Teleflex Inc.
• Angiodynamics Inc.
• MedWaves, Inc.
• Becton, Dickinson, and Company

Report Scope:

In this report, the Global Interventional Oncology Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Interventional Oncology Devices Market, By Product:

• Embolization Devices
• Ablation Devices
• Support Devices

Interventional Oncology Devices Market, By Procedure:

• Thermal Tumor Ablation
• Non-thermal Tumor Ablation
• Transcatheter Arterial Chemoembolization (TACE)
• Transcatheter Arterial Radioembolization (TARE)
• Transcatheter Arterial Embolization (TAE)

Interventional Oncology Devices Market, By Cancer Type:

• Liver
• Kidney
• Lung
• Bone
• Others

Interventional Oncology Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Interventional Oncology Devices Market.

Available Customizations:

Global Interventional Oncology Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Interventional Oncology Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Embolization Devices, Ablation Devices, Support Devices)
  • 5.2.2. By Procedure (Thermal Tumor Ablation, Non-thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Transcatheter Arterial Embolization (TAE))
  • 5.2.3. By Cancer Type (Liver, Kidney, Lung, Bone, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Interventional Oncology Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Procedure
  • 6.2.3. By Cancer Type
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Interventional Oncology Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Procedure
      • 6.3.1.2.3. By Cancer Type
  • 6.3.2. Canada Interventional Oncology Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Procedure
      • 6.3.2.2.3. By Cancer Type
  • 6.3.3. Mexico Interventional Oncology Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Procedure
      • 6.3.3.2.3. By Cancer Type

7. Europe Interventional Oncology Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Procedure
  • 7.2.3. By Cancer Type
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Interventional Oncology Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Procedure
      • 7.3.1.2.3. By Cancer Type
  • 7.3.2. France Interventional Oncology Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Procedure
      • 7.3.2.2.3. By Cancer Type
  • 7.3.3. United Kingdom Interventional Oncology Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Procedure
      • 7.3.3.2.3. By Cancer Type
  • 7.3.4. Italy Interventional Oncology Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Procedure
      • 7.3.4.2.3. By Cancer Type
  • 7.3.5. Spain Interventional Oncology Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Procedure
      • 7.3.5.2.3. By Cancer Type

8. Asia Pacific Interventional Oncology Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Procedure
  • 8.2.3. By Cancer Type
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Interventional Oncology Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Procedure
      • 8.3.1.2.3. By Cancer Type
  • 8.3.2. India Interventional Oncology Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Procedure
      • 8.3.2.2.3. By Cancer Type
  • 8.3.3. Japan Interventional Oncology Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Procedure
      • 8.3.3.2.3. By Cancer Type
  • 8.3.4. South Korea Interventional Oncology Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Procedure
      • 8.3.4.2.3. By Cancer Type
  • 8.3.5. Australia Interventional Oncology Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Procedure
      • 8.3.5.2.3. By Cancer Type

9. Middle East & Africa Interventional Oncology Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Procedure
  • 9.2.3. By Cancer Type
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Interventional Oncology Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Procedure
      • 9.3.1.2.3. By Cancer Type
  • 9.3.2. UAE Interventional Oncology Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Procedure
      • 9.3.2.2.3. By Cancer Type
  • 9.3.3. South Africa Interventional Oncology Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Procedure
      • 9.3.3.2.3. By Cancer Type

10. South America Interventional Oncology Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Procedure
  • 10.2.3. By Cancer Type
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Interventional Oncology Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Procedure
      • 10.3.1.2.3. By Cancer Type
  • 10.3.2. Colombia Interventional Oncology Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Procedure
      • 10.3.2.2.3. By Cancer Type
  • 10.3.3. Argentina Interventional Oncology Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Procedure
      • 10.3.3.2.3. By Cancer Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Interventional Oncology Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic PLC
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Terumo Corporation
• 15.3. Boston Scientific Corporation
• 15.4. Merit Medical Systems, Inc.
• 15.5. HealthTronics, Inc.
• 15.6. Johnson & Johnson
• 15.7. Teleflex Inc.
• 15.8. Angiodynamics Inc.
• 15.9. MedWaves, Inc.
• 15.10. Becton, Dickinson, and Company

16. Strategic Recommendations

17. About Us & Disclaimer

관련자료